-
(1R,2S,6R,7S)-4-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
-
ChemBase ID:
154461
-
Molecular Formular:
C21H29N5O2
-
Molecular Mass:
383.48726
-
Monoisotopic Mass:
383.23212519
-
SMILES and InChIs
SMILES:
c1cnc(nc1)N1CCN(CC1)CCCCN1C(=O)[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C1=O
Canonical SMILES:
O=C1N(CCCCN2CCN(CC2)c2ncccn2)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1
InChI:
InChI=1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18-
InChIKey:
CEIJFEGBUDEYSX-FZDBZEDMSA-N
-
Cite this record
CBID:154461 http://www.chembase.cn/molecule-154461.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
(1R,2S,6R,7S)-4-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
|
|
|
IUPAC Traditional name
|
|
Synonyms
|
(1R*,2S*,3R*,4S*)-N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-2,3-norbornanedicarboximide citrate salt
|
SM 3997
|
Tandospirone
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
H Acceptors
|
6
|
H Donor
|
0
|
LogD (pH = 5.5)
|
-0.609466
|
LogD (pH = 7.4)
|
1.0718763
|
Log P
|
1.4968145
|
Molar Refractivity
|
107.1089 cm3
|
Polarizability
|
40.89443 Å3
|
Polar Surface Area
|
69.64 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
T6704
|
Biochem/physiol Actions Tandospirone is a partial agonist at 5HT1A receptors. It significantly reduces haloperidol-induced bradykinesia in a dose-dependent manner. The potency of tandospirone is equal to that of buspirone and approximate half that of diazepam. The potency of tandospirone as a dopamine antagonistic is less than 1/4 that of buspirone. |
PATENTS
PATENTS
PubChem Patent
Google Patent